(Reuters) – U.S. private equity firm Blackstone Group Inc (BX.N) has secured $3.4 billion from investors for its first fund dedicated to investments in the life sciences sector, targeting $4.6 billion in total, a regulatory filing showed on Thursday.
Blackstone raises three-quarters of targeted $4.6 billion life sciences fund
This entry was posted in Syndicated. Bookmark the permalink.
